Literature DB >> 12376468

Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione.

J R Merwin1, D J Mustacich, E G D Muller, G D Pearson, G F Merrill.   

Abstract

Reporter gene transactivation by human p53 is compromised in S. cerevisiae lacking the TRR1 gene encoding thioredoxin reductase. The basis for p53 inhibition was investigated by measuring the redox state of thioredoxin and glutathione in wild-type and Deltatrr1 yeast. The Deltatrr1 mutation affected the redox state of both molecules. About 34% of thioredoxin was in the disulfide form in wild-type yeast and increased to 70% in Deltatrr1 yeast. About 18% of glutathione was in the GSSG form in wild-type yeast and increased to 32% in Deltatrr1 yeast. The Deltatrr1 mutation also resulted in a 2.9-fold increase in total glutathione per mg extract protein. Highcopy expression of the GLR1 gene encoding glutathione reductase in Deltatrr1 yeast restored the GSSG:GSH ratio to wild-type levels, but did not restore p53 activity. Also, p53 activity was shown to be unaffected by a Deltaglr1 mutation, even though the mutation was known to result in glutathione oxidation. In summary, the results show that, although glutathione becomes more oxidized in Deltatrr1 cells, glutathione oxidation is neither sufficient nor necessary for p53 inhibition. The results indicate that p53 activity has a specific requirement for an intact thioredoxin system, rather than a general dependence on the intracellular reducing environment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376468     DOI: 10.1093/carcin/23.10.1609

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

Review 1.  p53, aerobic metabolism, and cancer.

Authors:  Cory U Lago; Ho Joong Sung; Wenzhe Ma; Ping-yuan Wang; Paul M Hwang
Journal:  Antioxid Redox Signal       Date:  2011-04-14       Impact factor: 8.401

2.  Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines.

Authors:  Mohd A Yusuf; Trinette Chuang; G Jayarama Bhat; Kalkunte S Srivenugopal
Journal:  Free Radic Biol Med       Date:  2010-06-25       Impact factor: 7.376

3.  Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure.

Authors:  Gustav Nilsonne; Eric Olm; Adam Szulkin; Filip Mundt; Agnes Stein; Branka Kocic; Anna-Klara Rundlöf; Aristi P Fernandes; Mikael Björnstedt; Katalin Dobra
Journal:  J Exp Clin Cancer Res       Date:  2009-06-29

4.  Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress.

Authors:  Chinavenmeni S Velu; Suryakant K Niture; Catalin E Doneanu; Nagarajan Pattabiraman; Kalkunte S Srivenugopal
Journal:  Biochemistry       Date:  2007-06-08       Impact factor: 3.162

5.  Effect of thioredoxin deletion and p53 cysteine replacement on human p53 activity in wild-type and thioredoxin reductase null yeast.

Authors:  Christopher S Stoner; George D Pearson; Ahmet Koç; Jason R Merwin; Nathan I Lopez; Gary F Merrill
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

6.  Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome.

Authors:  Alla A Bondareva; Mario R Capecchi; Sonya V Iverson; Yan Li; Nathan I Lopez; Olivier Lucas; Gary F Merrill; Justin R Prigge; Ashley M Siders; Maki Wakamiya; Stephanie L Wallin; Edward E Schmidt
Journal:  Free Radic Biol Med       Date:  2007-05-31       Impact factor: 7.376

7.  The Thioredoxin System is Regulated by the ASK-1/JNK/p38/Survivin Pathway During Germ Cell Apoptosis.

Authors:  Nora Al-Kandari; Fatemah Fadel; Farah Al-Saleh; Farah Khashab; May Al-Maghrebi
Journal:  Molecules       Date:  2019-09-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.